Abstract
Adverse reactions to drugs constitute a serious problem in clinical practice, with respect to both their unpredictability and their sometimes life-threatening consequences. A large proportion of adverse drug reactions (estimates range from 10–50%) are labelled as ‘allergic’ or ‘hypersensitivity’ reactions, with the implication that the reaction is mediated by a specific immune response directed against the drug. Such classification of adverse reactions is based largely on symptoms alone, which may include skin rashes, fever, taste disturbance, and occasionally more serious disorders such as anaphylaxis, kidney dysfunction and cytopenias, all of which certainly can be caused by hypersensitivity reactions. For example, anaphylactic reactions and skin inflammation can be caused by cross-linking of cell-bound IgE by antigen, leading to release of histamine and other mast-cell-dependent chemical mediators (type I hypersensitivity); blood cells can be destroyed by antibody-dependent cytotoxic reactions (type II); inflammatory reactions and kidney dysfunction can be caused by immune complex deposition (type III); and inflammatory tissue reactions can also be T-cell-mediated (type IV). However, although certain symptoms may point to an immune aetiology, an adverse drug reaction can only be classified with certainty as a ‘hypersensitivity reaction’ or ‘drug allergy’ when drug-specific antibodies or sensitized T cells can be demonstrated. Even so, convincing evidence that an adverse reaction is immunologically mediated will only be obtained when the severity of the reaction is shown to relate to levels of circulating or tissue antibody or sensitized T cells. Hence, diagnosis of drug hypersensitivity depends on the development and correct use of appropriate laboratory tests for humoral and cellular indices of specific immune responses. Only when these immunological parameters are monitored in a quantitative manner will it be possible to relate drug dosage, distribution, disposition and metabolism to the induction of hypersensitivity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amos, H. E. (1973). Diagnosis of allergic drug reactions. Int. Archs. Allergy appl. Immun., 45, 218–231.
Amos, H. E., Lake, B. G., Artis, J. (1978). Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome. Br. Med. J., 1, 402–404.
Amos, H. E., Wilson, D. V., Taussig, M. J., Carlton, S. J. (1971). Hypersensitivity reactions to acetylsalicylic acid. I. Detection of antibodies in human sera using acetylsalicylic acid attached to proteins through the carboxyl group. Clin. exp. Immun., 8, 563–572.
Baldo, B. A., Fisher, M. M. (1983a). Detection of serum IgE antibodies that react with alcuronium and tubocurarine after lifethreatening reactions to muscle relaxant drugs. Anaesth. intens, care, 11, 194–197.
Baldo, B. A., Fisher, M. M. (1983b). Substituted ammonium ions as allergenic determinant in drug allergy. Nature, 306, 262–264.
Beaumont, J. L., Lemort, N., Lorenzelli-Edouard, L., Delplanque, B., Beaumont, V. (1979). Antiethinyloestradiol antibody activities in oral contraceptive users. Clin. exp. Immun., 38, 445–452.
Bommer, J., Wilhelms, O. H., Barth, H. P., Schindele, H., Ritz, E. (1985). Anaphylactoid reactions in dialysis patients: role of ethylene oxide. Lancet, ii, 1382–1384.
Closs, S. P., Cummins, D., Contreras, M., Armitage, S. E. (1984). Neutropenia due to methyldopa antibodies. Lancet, i, 1479.
Coleman, J. W., Yeung, J. H. K., Tingle, M. D., Park, B. K. (1986a). Enzymelinked immunosorbent assay (ELISA) for detection of antibodies to protein-reactive drugs and metabolites: criteria for identification of antibody activity. Detection and hapten specificity of anti-DNP, anti-captopril and anti-sul-phanilamidobenzoic acid. J. Immunol. Methods, 88, 37–44.
Coleman, J. W., Yeung, J. H. K., Roberts, D. H., Breckenridge, A. M., Park, B. K. (1986b). Drug-specific antibodies in patients receiving Captopril. Br. J. clin. Pharmac., 22, 161–165.
Daniel, T. M., Perloff, M., Major, J. J., Baum, G. L. (1968). The demonstration of antibodies to para-aminosalicylic acid in human serum. J. Lab. clin. Med., 72, 239–244.
Das, P. K., Klatser, P. R., Pondman, K. W., Huikeshoven, H., Landheer, J. E., Leiker, D. L., Rees, R. J. W. (1980). Dapsone and anti-dapsone antibody in circulating immune complexes in leprosy patients. Lancet, i, 1309–1310.
De Haan, P., Boorsma, D. M., Kalsbeek, G. L. (1979). Penicillin hyper-sensitivity. Determination and classification of anti-penicillin antibodies by the enzyme-linked immunosorbent assay. Allergy, 34, 111–119.
De Haan, P., Kalsbeek, G. L. (1983a). Induction of benzylpenicilloyl specific antibodies, including IgE, by long-term administration of benzylpenicillin. Clin. Allergy, 13, 563–569.
De Haan, P., Kalsbeek, G. L. (1983b). Humoral immune response to some benzylpenicillin preparations. Allergy, 38, 319–324.
Eddleston, A. L. W. F. and Williams, R. (1984). Antibodies to alcohol altered liver cell determinants in patients with alcoholic liver disease. Gut, 25, 300–304.
Foster, A. L., Park, B. K., Coleman, J. W. A specific enzyme-linked immunosorbent assay for definition of the IgG antibody response to disulphideconjugated D-penicillamine in the rabbit. Int. Archs. Allergy appl. Immun., 84, 271–276.
Garrido, M. J., Gorvin, J., Moreno, C. (1979). Characterisation of the reaginic response to sulphonamides in mice. Int. Archs. Allergy appl Immun., 60, 154–160.
Harle, D. G., Baldo, B. A., Fisher, M. M. (1984). Detection of IgE antibodies to suxamethonium after anaphylactoid reactions during anaesthesis. Lancet, i, 930–932.
Huikeshoven, H., Landheer, J. E., Ven Denderen, A.C., Vlasman, M., Leiker, D. L., Das, P. K., Goldring, O. L., Pondman, K. W. (1978). Demonstration of dapsone in urine and serum by ELISA inhibition. Lancet, i, 280–281.
Kenna, J. G., Neuberger, J., Williams, R. (1984). An enzyme-linked immunosorbent assay for detection of antibodies against halothane-altered hepatocyte antigens. J. Immunol. Methods, 75, 3–14.
Kitteringham, N. R., Christie, G., Coleman, J. W., Yeung, J. H. K., Park, B. K. (1987). Drug-protein conjugates XII. A study of the disposition, irreversible binding and immunogenicity of penicillin in the rat. Biochem. Pharmacol., 36, 601–608.
MacSween, R. N. M., Anthony, R. S., Farquharson, M. (1981). Antibodies to alcohol-altered hepatocytes in patients with alcoholic liver disease. Lancet, ii, 803–804.
Park, B. K., Coleman, J. W., Kitteringham, N. R. (1987). Commentary: drug disposition and drug hypersensitivity. Biochem. Pharmacol., 36, 581–590.
Park, B. K., Grabowski, P. S., Yeung, J. H. K., Breckenridge, A. M. (1982). Drug protein conjugates I. A study of the covalent binding of [14C] Captopril to plasma proteins in the rat. Biochem. Pharmacol., 31, 1755–1760.
Park, B. K., Whittaker, A. D. (1978). An immunochemical study of the hapten formed from ethynyloestradiol and guinea pig liver microsomes. FEBS Letters, 91, 273–275.
Ryan, J. J., Parker, C. W., Williams, R. C. (1972). γ-Globulin binding of morphine in heroin addicts. J. Lab. clin. Med., 80, 155–164.
Salama, A., Mueller-Eckhardt, C. (1985). The role of metabolite specific antibodies in nomifensine-dependent immune hemolytic anemia. New Engl. J. Med., 313, 469–474.
Schulthess, H. K., von Feiten, A., Gmür, J., Neftel, K. (1983). Amodiaquininduzierte Agranulozytose bei Malariaprophylaxe: Nachweis eines amodiaquine-abhängigen zytotoxischen Antikörpers gegen Granulozyten. Sweiz. med. Wschr., 113, 1912–1913.
Spath, P., Garratty, G., Petz, L. (1971). Studies on the immune response to penicillin and cephalothin in humans. J. Immun., 107, 854–869.
Steward, M. W., Lew, A. M. (1985). The importance of antibody affinity in the performance of immunoassays for antibody. J. Immunol. Methods, 78, 173–190.
Stricker, B. H., Barendregt, J. N. M., Claas, F. H. J. (1985). Thrombocytopenia and leucopenia with mianserin-dependent antibodies. Br. J. clin. Pharmac, 19, 102–104.
Yeung, J. H. K., Coleman, J. W., Park, B. K. (1985). Drug-protein conjugates IX. Immunogenicity of captopril-protein conjugates. Biochem. Pharmacol., 34, 4005–4012.
Editor information
Editors and Affiliations
Copyright information
© 1988 S. B. Pal and the Contributors
About this chapter
Cite this chapter
Coleman, J.W. (1988). Enzyme-linked Immunossays for Detection of Anti-drug Antibodies. In: Pal, S.B. (eds) Reviews on Immunoassay Technology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-10318-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-349-10318-8_10
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-10320-1
Online ISBN: 978-1-349-10318-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)